Shellie Fravel, PharmD
@shelliefravel.bsky.social
Pharmacist | Clinical Professor
✨Interest in Nephrology Medicine #NephJC #NephSky
✨Interest in Nephrology Medicine #NephJC #NephSky
Reposted by Shellie Fravel, PharmD
Excited to share our research letter published today in JAMA on the new Apple Watch Hypertension Notification Feature! jamanetwork.com/journals/jam...
1/n
1/n
Smartwatch and Hypertension Notification
This cross-sectional study assesses the potential impact of a smartwatch hypertension notification feature for US adults who have not been diagnosed with hypertension.
jamanetwork.com
February 9, 2026 at 5:21 PM
Excited to share our research letter published today in JAMA on the new Apple Watch Hypertension Notification Feature! jamanetwork.com/journals/jam...
1/n
1/n
Reposted by Shellie Fravel, PharmD
Hey #NephSky
2/10/26 at 9 pm EST we'll discuss
#Flozinating into the Future & Beyond...
SGLT2i in kidney transplant recipients.
What's the latest evidence of risk/benefit?
Do #Flozins act mechanistically the same in de-innervated kidneys?
Come chat.
www.nephjc.com/news/inifinti-flozins-transplant
2/10/26 at 9 pm EST we'll discuss
#Flozinating into the Future & Beyond...
SGLT2i in kidney transplant recipients.
What's the latest evidence of risk/benefit?
Do #Flozins act mechanistically the same in de-innervated kidneys?
Come chat.
www.nephjc.com/news/inifinti-flozins-transplant
To INFINITI and Beyond: SGLT2 Inhibitors in Kidney Transplant Patients — NephJC
This week, we aim for an INFINITe allograft lifespan. or flozination in kidney transplant.
www.nephjc.com
February 8, 2026 at 11:25 PM
Hey #NephSky
2/10/26 at 9 pm EST we'll discuss
#Flozinating into the Future & Beyond...
SGLT2i in kidney transplant recipients.
What's the latest evidence of risk/benefit?
Do #Flozins act mechanistically the same in de-innervated kidneys?
Come chat.
www.nephjc.com/news/inifinti-flozins-transplant
2/10/26 at 9 pm EST we'll discuss
#Flozinating into the Future & Beyond...
SGLT2i in kidney transplant recipients.
What's the latest evidence of risk/benefit?
Do #Flozins act mechanistically the same in de-innervated kidneys?
Come chat.
www.nephjc.com/news/inifinti-flozins-transplant
Reposted by Shellie Fravel, PharmD
PBFluids▶️PISCES showed a striking cardiovascular benefit with fish oil in hemodialysis. Lovaza closely matches the trial’s ethyl-ester formulation, is FDA regulated, EHR friendly, and offers a practical option while we wait for the exact formulation pbfluids.com/2026/01/why-...
Why aren’t you prescribing fish oil to your dialysis patients?
PISCES showed a striking cardiovascular benefit with fish oil in hemodialysis. Lovaza closely matches the trial’s ethyl-ester formulation, is FDA regulated, EHR friendly, and offers a practical, re…
pbfluids.com
January 28, 2026 at 1:49 PM
PBFluids▶️PISCES showed a striking cardiovascular benefit with fish oil in hemodialysis. Lovaza closely matches the trial’s ethyl-ester formulation, is FDA regulated, EHR friendly, and offers a practical option while we wait for the exact formulation pbfluids.com/2026/01/why-...
Reposted by Shellie Fravel, PharmD
January 28, 2026 at 2:56 AM
Reposted by Shellie Fravel, PharmD
🍌🥑Can pushing K⁺ to the high-normal range reduce ICD shocks and hospitalizations?
🎨 #Visualabstract by @jeyakumarmeyyappan.bsky.social
⏰ #NephJC chat on Jan 27, 9 pm EST
www.nephjc.com/news/2026/1/...
🎨 #Visualabstract by @jeyakumarmeyyappan.bsky.social
⏰ #NephJC chat on Jan 27, 9 pm EST
www.nephjc.com/news/2026/1/...
January 26, 2026 at 9:05 AM
🍌🥑Can pushing K⁺ to the high-normal range reduce ICD shocks and hospitalizations?
🎨 #Visualabstract by @jeyakumarmeyyappan.bsky.social
⏰ #NephJC chat on Jan 27, 9 pm EST
www.nephjc.com/news/2026/1/...
🎨 #Visualabstract by @jeyakumarmeyyappan.bsky.social
⏰ #NephJC chat on Jan 27, 9 pm EST
www.nephjc.com/news/2026/1/...
Reposted by Shellie Fravel, PharmD
Oh, the weather outside is frightful 🥶🥶
But #NephJC is so delightful,
and since you've no place to go #NephSky...
Come discuss POTCAST: potassium goals and cardiac arrhythmias 1/27/26 at 9pm EST on #Bluesky
Summary by @shelliefravel.bsky.social @salinesolut.bsky.social
www.nephjc.com/news/potcast
But #NephJC is so delightful,
and since you've no place to go #NephSky...
Come discuss POTCAST: potassium goals and cardiac arrhythmias 1/27/26 at 9pm EST on #Bluesky
Summary by @shelliefravel.bsky.social @salinesolut.bsky.social
www.nephjc.com/news/potcast
POTCAST- K+ Pop and Arrhythmia Drop — NephJC
This week, we will discuss the POTCAST trial. It is a cardiology trial - but potassium belongs to nephrology.
www.nephjc.com
January 26, 2026 at 9:47 PM
Oh, the weather outside is frightful 🥶🥶
But #NephJC is so delightful,
and since you've no place to go #NephSky...
Come discuss POTCAST: potassium goals and cardiac arrhythmias 1/27/26 at 9pm EST on #Bluesky
Summary by @shelliefravel.bsky.social @salinesolut.bsky.social
www.nephjc.com/news/potcast
But #NephJC is so delightful,
and since you've no place to go #NephSky...
Come discuss POTCAST: potassium goals and cardiac arrhythmias 1/27/26 at 9pm EST on #Bluesky
Summary by @shelliefravel.bsky.social @salinesolut.bsky.social
www.nephjc.com/news/potcast
Reposted by Shellie Fravel, PharmD
Sodium-Glucose Cotransporter-2 Inhibitors #SGLT2i and #Cardiorenal Events in #Nonalbuminuric Kidney Disease
#VisualAbstract by Augusto Cesar S Santos Jr
https://www.kireports.org/article/S2468-0249(25)00774-0/fulltext
@cwhuang0824
#VisualAbstract by Augusto Cesar S Santos Jr
https://www.kireports.org/article/S2468-0249(25)00774-0/fulltext
@cwhuang0824
January 21, 2026 at 2:01 PM
Sodium-Glucose Cotransporter-2 Inhibitors #SGLT2i and #Cardiorenal Events in #Nonalbuminuric Kidney Disease
#VisualAbstract by Augusto Cesar S Santos Jr
https://www.kireports.org/article/S2468-0249(25)00774-0/fulltext
@cwhuang0824
#VisualAbstract by Augusto Cesar S Santos Jr
https://www.kireports.org/article/S2468-0249(25)00774-0/fulltext
@cwhuang0824
Reposted by Shellie Fravel, PharmD
Can measuring glomerular filtration finally be easy?
#nephsky #nephrology
www.kireports.org/article/S246...
#nephsky #nephrology
www.kireports.org/article/S246...
Can measuring glomerular filtration finally be easy?
Assessment of glomerular filtration rate (GFR) has progressed through a series of
practical trade-offs between physiological accuracy and clinical feasibility. Direct
measurement of GFR using exogenou...
www.kireports.org
January 22, 2026 at 3:28 AM
Can measuring glomerular filtration finally be easy?
#nephsky #nephrology
www.kireports.org/article/S246...
#nephsky #nephrology
www.kireports.org/article/S246...
Reposted by Shellie Fravel, PharmD
It's 2026!🎉
We will be counting down the Top Ten Nephrology Stories of 2025 on 1/6/26 at 9 pm EST.
Join us on TWITTER (it will always be Twitter to us).
Come on by #NephJC faithful for a lively discussion! You picked & we're count'em down.
www.nephjc.com/news/2025/1/3/top-stories-in-nephrology-2025
We will be counting down the Top Ten Nephrology Stories of 2025 on 1/6/26 at 9 pm EST.
Join us on TWITTER (it will always be Twitter to us).
Come on by #NephJC faithful for a lively discussion! You picked & we're count'em down.
www.nephjc.com/news/2025/1/3/top-stories-in-nephrology-2025
Top Stories in Nephrology 2025 — NephJC
2025 was rich in successful stories. Here are the top 10 that impressed our audience.
www.nephjc.com
January 3, 2026 at 7:03 PM
It's 2026!🎉
We will be counting down the Top Ten Nephrology Stories of 2025 on 1/6/26 at 9 pm EST.
Join us on TWITTER (it will always be Twitter to us).
Come on by #NephJC faithful for a lively discussion! You picked & we're count'em down.
www.nephjc.com/news/2025/1/3/top-stories-in-nephrology-2025
We will be counting down the Top Ten Nephrology Stories of 2025 on 1/6/26 at 9 pm EST.
Join us on TWITTER (it will always be Twitter to us).
Come on by #NephJC faithful for a lively discussion! You picked & we're count'em down.
www.nephjc.com/news/2025/1/3/top-stories-in-nephrology-2025
Reposted by Shellie Fravel, PharmD
Did we (meaning "you" of course, because you voted) get them right? Is there something missing or is the order wrong? #NephJC #TopTenStories2025
Come discuss with an international cadre of nephrologists & other interested parties on 1/6/26 at 9 pm EST on #Twitter
Come discuss with an international cadre of nephrologists & other interested parties on 1/6/26 at 9 pm EST on #Twitter
January 3, 2026 at 7:06 PM
Did we (meaning "you" of course, because you voted) get them right? Is there something missing or is the order wrong? #NephJC #TopTenStories2025
Come discuss with an international cadre of nephrologists & other interested parties on 1/6/26 at 9 pm EST on #Twitter
Come discuss with an international cadre of nephrologists & other interested parties on 1/6/26 at 9 pm EST on #Twitter
Reposted by Shellie Fravel, PharmD
The future of nephrology
2/🚨Our topic🚨A Comprehensive Framework for Kidney Function Assessment: Summary of the NIDDKD Reimagining Kidney Function Assessment Workshop
👉 www.kireports.org/article/S246...
@pbjornstad.bsky.social @danafuhrman.bsky.social @jaykoyner.bsky.social @waikarss.bsky.social @isnkidneycare.bsky.social
👉 www.kireports.org/article/S246...
@pbjornstad.bsky.social @danafuhrman.bsky.social @jaykoyner.bsky.social @waikarss.bsky.social @isnkidneycare.bsky.social
December 18, 2025 at 6:34 AM
The future of nephrology
Reposted by Shellie Fravel, PharmD
1/10
Last #NephJC we discussed dialysis frequency in AKI-D #TenPostNephJC
We sought to answer an age-old question: Is less is really more? Or less is just simply what it is….less?
pubmed.ncbi.nlm.nih.gov/41201895/
Last #NephJC we discussed dialysis frequency in AKI-D #TenPostNephJC
We sought to answer an age-old question: Is less is really more? Or less is just simply what it is….less?
pubmed.ncbi.nlm.nih.gov/41201895/
December 19, 2025 at 12:23 PM
1/10
Last #NephJC we discussed dialysis frequency in AKI-D #TenPostNephJC
We sought to answer an age-old question: Is less is really more? Or less is just simply what it is….less?
pubmed.ncbi.nlm.nih.gov/41201895/
Last #NephJC we discussed dialysis frequency in AKI-D #TenPostNephJC
We sought to answer an age-old question: Is less is really more? Or less is just simply what it is….less?
pubmed.ncbi.nlm.nih.gov/41201895/
Reposted by Shellie Fravel, PharmD
The debate about kidney function estimation in cancer patients is not over. What is important to remember is that mCrCl is not mGFR
Significant overestimation of renal function by eGFR compared to measured CrCl in people with nonmetastatic RCC (including Cys C-adjusted).
Wide implications re: cystectomy cutoffs. #UroSky #NephSky is this part of your practice for people near cutoff?
ascopubs.org/doi/10.1200/... #MedSky #JCOOP
Wide implications re: cystectomy cutoffs. #UroSky #NephSky is this part of your practice for people near cutoff?
ascopubs.org/doi/10.1200/... #MedSky #JCOOP
December 17, 2025 at 12:21 PM
The debate about kidney function estimation in cancer patients is not over. What is important to remember is that mCrCl is not mGFR
Reposted by Shellie Fravel, PharmD
Less dialysis is…less dialysis. #NephJC
Sure I’d like to see faster recovery and lower mortality. But what if conservative strategy is only “non-inferior”. Is that good enough, especially if dialysis is a limited resource like @nephroseeker.bsky.social says
Sure I’d like to see faster recovery and lower mortality. But what if conservative strategy is only “non-inferior”. Is that good enough, especially if dialysis is a limited resource like @nephroseeker.bsky.social says
December 17, 2025 at 2:32 AM
Less dialysis is…less dialysis. #NephJC
Sure I’d like to see faster recovery and lower mortality. But what if conservative strategy is only “non-inferior”. Is that good enough, especially if dialysis is a limited resource like @nephroseeker.bsky.social says
Sure I’d like to see faster recovery and lower mortality. But what if conservative strategy is only “non-inferior”. Is that good enough, especially if dialysis is a limited resource like @nephroseeker.bsky.social says
Reposted by Shellie Fravel, PharmD
Join us for the last #NephJC of 2025, 12/16/25 at 9pm EST!🥳
How soon should we withhold dialysis in AKI?
We're discussing the LIBERATE-D trial #NephSky
This one might just change your mind 🧠🧠
Blog by @msocomd.bsky.social and @sejalplakhani.bsky.social
www.nephjc.com/news/liberated-aki
How soon should we withhold dialysis in AKI?
We're discussing the LIBERATE-D trial #NephSky
This one might just change your mind 🧠🧠
Blog by @msocomd.bsky.social and @sejalplakhani.bsky.social
www.nephjc.com/news/liberated-aki
Dialyze Less, Recover More? AKI’s Chance to Get LIBERATE-D — NephJC
This week, we will discuss whether less is more when it comes to discontinuing dialysis in patients with AKI and a chance to recover.
www.nephjc.com
December 15, 2025 at 2:41 PM
Join us for the last #NephJC of 2025, 12/16/25 at 9pm EST!🥳
How soon should we withhold dialysis in AKI?
We're discussing the LIBERATE-D trial #NephSky
This one might just change your mind 🧠🧠
Blog by @msocomd.bsky.social and @sejalplakhani.bsky.social
www.nephjc.com/news/liberated-aki
How soon should we withhold dialysis in AKI?
We're discussing the LIBERATE-D trial #NephSky
This one might just change your mind 🧠🧠
Blog by @msocomd.bsky.social and @sejalplakhani.bsky.social
www.nephjc.com/news/liberated-aki
Reposted by Shellie Fravel, PharmD
The LIBERATE-D VA by
@sejalplakhani.bsky.social
Should we break the pattern of thrice weekly dialysis in AKI-D? #NephJC #NephSky
www.nephjc.com/news/liberateva
@sejalplakhani.bsky.social
Should we break the pattern of thrice weekly dialysis in AKI-D? #NephJC #NephSky
www.nephjc.com/news/liberateva
LIBERATE-D: The Visual Abstract — NephJC
In patients with dialysis-dependent acute kidney injury, a conservative dialysis strategy was evaluated in the LIBERATE-D trial. Could less be more? Join the discussion in #NephJC, but first, check ou...
www.nephjc.com
December 15, 2025 at 2:43 PM
The LIBERATE-D VA by
@sejalplakhani.bsky.social
Should we break the pattern of thrice weekly dialysis in AKI-D? #NephJC #NephSky
www.nephjc.com/news/liberateva
@sejalplakhani.bsky.social
Should we break the pattern of thrice weekly dialysis in AKI-D? #NephJC #NephSky
www.nephjc.com/news/liberateva
Reposted by Shellie Fravel, PharmD
Our take on the baxdrostat PA trial in @asnpublications.bsky.social #KidneyNews
www.kidneynews.org/view/journal... with @nephroseeker.medsky.social and @dramiliflores.bsky.social !
Thanks to Sam Kant and @kdjhaveri.bsky.social for the invite!!
www.kidneynews.org/view/journal... with @nephroseeker.medsky.social and @dramiliflores.bsky.social !
Thanks to Sam Kant and @kdjhaveri.bsky.social for the invite!!
December 9, 2025 at 2:33 AM
Our take on the baxdrostat PA trial in @asnpublications.bsky.social #KidneyNews
www.kidneynews.org/view/journal... with @nephroseeker.medsky.social and @dramiliflores.bsky.social !
Thanks to Sam Kant and @kdjhaveri.bsky.social for the invite!!
www.kidneynews.org/view/journal... with @nephroseeker.medsky.social and @dramiliflores.bsky.social !
Thanks to Sam Kant and @kdjhaveri.bsky.social for the invite!!
Yes so…
-Lovaza 3 capsules 1395 EPA / 1125 DHA
-Lovaza 4 capsules 1860 EPA / 1500 DHA
vs
-Study 4 capsules 1600 EPA / 800 DHA
I guess the question is if either regimen is close enough to presume equal benefit/safety?
-Lovaza 3 capsules 1395 EPA / 1125 DHA
-Lovaza 4 capsules 1860 EPA / 1500 DHA
vs
-Study 4 capsules 1600 EPA / 800 DHA
I guess the question is if either regimen is close enough to presume equal benefit/safety?
December 4, 2025 at 12:04 AM
Yes so…
-Lovaza 3 capsules 1395 EPA / 1125 DHA
-Lovaza 4 capsules 1860 EPA / 1500 DHA
vs
-Study 4 capsules 1600 EPA / 800 DHA
I guess the question is if either regimen is close enough to presume equal benefit/safety?
-Lovaza 3 capsules 1395 EPA / 1125 DHA
-Lovaza 4 capsules 1860 EPA / 1500 DHA
vs
-Study 4 capsules 1600 EPA / 800 DHA
I guess the question is if either regimen is close enough to presume equal benefit/safety?
Have you tried prescribing generic Lovaza? I think that it’s a close match to the EPA/DHA content in the trial if you order 2 capsules BID.
December 3, 2025 at 8:38 PM
Have you tried prescribing generic Lovaza? I think that it’s a close match to the EPA/DHA content in the trial if you order 2 capsules BID.
I think Lovaza is close. Each 1g capsule contains 465 mg EPA and 375 mg DHA and is dosed as 4 capsules a day for high TG. It is also available generic now so reasonably priced. #NephJC www.costplusdrugs.com/medications/...
Omega 3 Acid Ethyl Esters 1gm Capsule | Cost Plus Drugs
Buy Omega 3 Acid Ethyl Esters 1gm Capsule at Mark Cuban Cost Plus Drug Company
www.costplusdrugs.com
December 3, 2025 at 12:51 PM
I think Lovaza is close. Each 1g capsule contains 465 mg EPA and 375 mg DHA and is dosed as 4 capsules a day for high TG. It is also available generic now so reasonably priced. #NephJC www.costplusdrugs.com/medications/...
Reposted by Shellie Fravel, PharmD
Maybe the most shocking study from #KidneyWk.
🐚From the depths of the oceans to #BlueSky, we're discussing PISCES 🐟 12/2/25 9pm EST. #NephJC
Are you hooked🪝on fish oil for CV disease in ESRD, or are you throwing it back 🌊?
www.nephjc.com/news/pisces-fishoil
🐚From the depths of the oceans to #BlueSky, we're discussing PISCES 🐟 12/2/25 9pm EST. #NephJC
Are you hooked🪝on fish oil for CV disease in ESRD, or are you throwing it back 🌊?
www.nephjc.com/news/pisces-fishoil
Fish Oil in Dialysis: A Big Catch or an Empty Net — NephJC
Holy Mackerel! This week we will discuss fish oil use in maintenance hemodialysis patients. Could this be the one thing that bends the curve on CV mortality, or is it just a red herring?
www.nephjc.com
December 1, 2025 at 6:41 PM
Maybe the most shocking study from #KidneyWk.
🐚From the depths of the oceans to #BlueSky, we're discussing PISCES 🐟 12/2/25 9pm EST. #NephJC
Are you hooked🪝on fish oil for CV disease in ESRD, or are you throwing it back 🌊?
www.nephjc.com/news/pisces-fishoil
🐚From the depths of the oceans to #BlueSky, we're discussing PISCES 🐟 12/2/25 9pm EST. #NephJC
Are you hooked🪝on fish oil for CV disease in ESRD, or are you throwing it back 🌊?
www.nephjc.com/news/pisces-fishoil
Reposted by Shellie Fravel, PharmD
Holy Mackerel! 🐟
🦜Ahoy matey! Could fish oil unlock the mysteries of increased CV mortality in ESRD? 🏴☠️ #NephJC
Join us for a lively trawling trip 12/2/25 🛥️at 9pm EST
Check out the PISCES VA by @brianrifkin.bsky.social
www.nephjc.com/news/piscesva
🦜Ahoy matey! Could fish oil unlock the mysteries of increased CV mortality in ESRD? 🏴☠️ #NephJC
Join us for a lively trawling trip 12/2/25 🛥️at 9pm EST
Check out the PISCES VA by @brianrifkin.bsky.social
www.nephjc.com/news/piscesva
PISCES: The Visual Abstract — NephJC
Curious how n-3 PUFAs may cut serious cardiovascular events in dialysis? 🐟 A big signal, a big dose, and a big discussion ahead — don’t miss this #NephJC! Check out the VA made by our master Brian...
www.nephjc.com
December 1, 2025 at 6:47 PM
Holy Mackerel! 🐟
🦜Ahoy matey! Could fish oil unlock the mysteries of increased CV mortality in ESRD? 🏴☠️ #NephJC
Join us for a lively trawling trip 12/2/25 🛥️at 9pm EST
Check out the PISCES VA by @brianrifkin.bsky.social
www.nephjc.com/news/piscesva
🦜Ahoy matey! Could fish oil unlock the mysteries of increased CV mortality in ESRD? 🏴☠️ #NephJC
Join us for a lively trawling trip 12/2/25 🛥️at 9pm EST
Check out the PISCES VA by @brianrifkin.bsky.social
www.nephjc.com/news/piscesva